Ultraviolet Study of the Active Interacting Binary Star R Arae using Archival IUE Data

The eclipsing and strongly interacting binary star system R Arae (HD149730) is in a very active and very short-lived stage of its evolution. R Ara consists of a B9V primary and an unknown secondary. We have collected the International Ultraviolet Explorer (IUE) archival data on R Ara, with most of the data being studied for the first time. There are 117 high resolution IUE spectra taken in 1980, 1982, 1985, 1989, and 1991. We provide photometric and spectroscopic evidence for mass transfer and propose a geometry for the accretion structure. We use colour scale radial velocity plots to view the complicated behavior of the blended absorption features and to distinguish the motions of hotter and cooler regions within the system. We observed a primary eclipse of R Ara in 2008 and have verified that its period is increasing. A model of the system and its evolutionary status is presented.Comment: 13 pages, 15 figures, accepted for publication in MNRA

Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure A Randomized Trial

In the SOLOIST-WHF (Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure) trial, sotagliflozin, a sodium-glucose cotransporter-1 and sodium-glucose cotransporter-2 inhibitor, reduced total occurrences of cardiovascular deaths, hospitalizations for heart failure, and urgent visits for heart failure relative to placebo by 33%

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes

To assess the safety and efficacy of dual sodium–glucose cotransporter (SGLT) 1 and SGLT2 inhibition with sotagliflozin as adjunct therapy to insulin in type 1 diabetes

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Funder: NCI U24CA211006Abstract: The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus somatic mutation calls using whole exome sequencing (WES) and whole genome sequencing (WGS), respectively. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2,658 cancers across 38 tumour types, we compare WES and WGS side-by-side from 746 TCGA samples, finding that ~80% of mutations overlap in covered exonic regions. We estimate that low variant allele fraction (VAF < 15%) and clonal heterogeneity contribute up to 68% of private WGS mutations and 71% of private WES mutations. We observe that ~30% of private WGS mutations trace to mutations identified by a single variant caller in WES consensus efforts. WGS captures both ~50% more variation in exonic regions and un-observed mutations in loci with variable GC-content. Together, our analysis highlights technological divergences between two reproducible somatic variant detection efforts

Improving the efficiency of haploid wheat production mediated by wide crossing

[Summary]: This study examined several possible means of improving the wheat (Triticum aestivum L.) x maize (Zea mays L.) method for haploid production in Australian hard white spring wheat genotypes. Two wheat varieties were pollinated by each of five maize lines, giving an average of 22 embryos per 100 florets. One maize inbred gave a significantly lower haploid embryo yield. Embryos rescued 12 or 15 days post pollination had a significantly higher germination percentage (51 to 80%) than embryos rescued 9, 17, 19 or 21 days after pollination (6.4 to 31%). Embryos 12 to 15 days old were found to be large and easily rescued. Haploid wheat embryos germinated at equal frequencies on four commercial tissue culture media and germination frequency was not affected by differing levels of 6-benzylarninopurine (BAP). However, the rate at which haploid embryos germinated was found to be significantly affected by both the type of medium and the Cytokinin level. Haploid embryos germinated fastest on an MS based medium with 0.05 mg/L BAP